|
WO2018088464A1
|
|
Therapeutic agent for cerebral infarction
|
|
AU2014200688A1
|
|
Pharmaceuticals that promote functional regeneration of damaged tissues
|
|
EP2913059A1
|
|
Novel method for treating spinal cord injury using hmgb1 fragment
|
|
EP2703487A1
|
|
Peptide for inducing regeneration of tissue and use thereof
|
|
CA2778759A1
|
|
Tissue-regeneration promoter using recruitment of bone marrow mesenchymal stem cells and/or pluripotent stem cells in blood
|
|
JP2011092065A
|
|
Implantable in vivo substance-collecting device
|
|
AU2009240885A1
|
|
Pharmaceutical agent for promoting the functional regeneration of damaged tissue
|
|
KR20110028440A
|
|
Agent for recruitment of bone-marrow-derived pluripotent stem cell into peripheral circulation
|
|
KR20160070169A
|
|
Method for collecting functional cells in vivo with high efficiency
|
|
KR20090078304A
|
|
Pharmaceutical for promoting functional regeneration of damaged tissue
|
